# ClinicalTrials.gov record NCT04053270

> PeptideScanner retained ClinicalTrials.gov record NCT04053270 at 2026-07-30T20:44:36.678Z. Its registry update date was 2019-10-10, and PeptideScanner's reviewed identity mapping was afamelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04053270-afamelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-10-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04053270-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04053270-afamelanotide-v1.json
- Content SHA-256: `a5d76d28d955512299a24b437da472037e0d4897af2a9d2d85821551d44eb8a5`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04053270 ([`ctg-observation-nct04053270-2019-10-10-958cf6582e5e`](#source-ctg-observation-nct04053270-2019-10-10-958cf6582e5e))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04053270 at 2026-07-30T20:44:36.678Z. Its registry update date was 2019-10-10, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct04053270-2019-10-10-958cf6582e5e`](#source-ctg-observation-nct04053270-2019-10-10-958cf6582e5e))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04053270 at 2026-07-30T20:44:36.678Z. Its registry update date was 2019-10-10, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct04053270-2019-10-10-958cf6582e5e`](#source-ctg-observation-nct04053270-2019-10-10-958cf6582e5e))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04053270-2019-10-10-958cf6582e5e`](#source-ctg-observation-nct04053270-2019-10-10-958cf6582e5e))

## Sources

<a id="source-ctg-observation-nct04053270-2019-10-10-958cf6582e5e"></a>
- **ClinicalTrials.gov record NCT04053270 · retained source version 2019-10-10:958cf6582e5ed7988165f7a95f44ac8fc8a27fac9ffdf2d2d3cea236ec4e09b6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04053270) (`ctg-observation-nct04053270-2019-10-10-958cf6582e5e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04053270." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04053270-afamelanotide-v1.json SHA-256: a5d76d28d955512299a24b437da472037e0d4897af2a9d2d85821551d44eb8a5.